Inhibition of the renin angiotensin system: Implications for the endothelium
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11892-006-0060-5.pdf
Reference61 articles.
1. Schiffrin EL, Touyz RM: From bedside to bench to bedside: role of the renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol 2004, 287:H435-H446.
2. Savoia C, Schiffrin EL: Inflammation in hypertension. Curr Opin Nephrol Hypertens 2006, 15:152–158.
3. Touyz R: Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II. Curr Opin Nephrol Hypertens 2005, 14:125–131.
4. Feldman RD, Gros R: Impaired vasodilator function in hypertension. The role of alterations in receptor-G protein coupling. Trends Cardiovasc Med 1988, 8:297–305.
5. Lamping K: Interactions between NO and cAMP in the regulation of vascular tone. Arterioscler Thromb Vasc Biol 2001, 21:729–730.
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. From cardiovascular system to brain, the potential protective role of Mas Receptors in COVID-19 infection;European Journal of Pharmacology;2023-11
2. Prevalence of anemia and associated factors among adult hypertensive patients in Referral Hospitals, Amhara Regional State;Scientific Reports;2023-08-31
3. Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications;Frontiers in Medicine;2022-01-20
4. Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trial;EClinicalMedicine;2021-11
5. The angiotensin type 2 receptor agonist C21 restores respiratory function in COVID19 - a double-blind, randomized, placebo-controlled Phase 2 trial;2021-01-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3